Ocular tear growth factor-like protein
The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.
1. A method of treating patients having deficient tear output, said method comprising the step of contacting the ocular surface with a composition comprising a polypeptide, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 4.
2. A method of enhancing the proliferation of human corneal epithelial cells or lacrimal acinar cells, said method comprising the step of contacting said cells with a composition comprising a polypeptide, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 4.